Reductions in Use of Colchicine after FDA Enforcement of Market Exclusivity in a Commercially Insured Population

摘要

BackgroundA brand-name version of colchicine (Colcrys) was introduced after its manufacturer conducted a clinical trial in acute gout patients, leading to higher prices for this drug.